Myocardial Metabolism in Heart Failure with Preserved Ejection Fraction
Heart failure with preserved ejection fraction (HFpEF) is increasingly prevalent and now accounts for half of all heart failure cases. This rise is largely attributed to growing rates of obesity, hypertension, and diabetes. Despite its prevalence, the pathophysiological mechanisms of HFpEF are not f...
Asıl Yazarlar: | Henry, JA, Couch, LS, Rider, OJ |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
MDPI
2024
|
Benzer Materyaller
-
Intentional weight loss as a novel treatment for heart failure with preserved ejection fraction
Yazar:: Hundertmark, MJ, ve diğerleri
Baskı/Yayın Bilgisi: (2021) -
Heart failure with preserved ejection fraction
Yazar:: Harper, A, ve diğerleri
Baskı/Yayın Bilgisi: (2018) -
Energetic basis for exercise-induced pulmonary congestion in heart failure with preserved ejection fraction
Yazar:: Burrage, MK, ve diğerleri
Baskı/Yayın Bilgisi: (2021) -
Astragaloside IV alleviates inflammation and improves myocardial metabolism in heart failure mice with preserved ejection fraction
Yazar:: Xiao Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01) -
The Role of Myocardial Ischemia in the Course of Heart Failure with Preserved Ejection Fraction in Patients with Cardiorenal Metabolic Syndrome
Yazar:: Yevhen Yu. Marushko, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)